Literature DB >> 12737524

Estrogen and neurodegeneration.

Sam Gandy1.   

Abstract

Although estrogen is best known for its effects on the maturation and differentiation of the primary and secondary sex organs, increasing evidence suggests that its influence extends beyond this system, and its activity in the CNS may initiate, or influence our susceptibility to neurodegenerative decline. Estrogen has been proposed to act as a neuroprotectant at several levels, and it is probable that deprivation of estrogen as a result of menopause exposes the aging or diseased brain to several insults. In addition, estrogen deprivation is likely to initiate or enhance degenerative changes caused by oxidative stress, and to reduce the brain's ability to maintain synaptic connectivity and cholinergic integrity leading to the cognitive decline seen in aged and disease-afflicted individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737524     DOI: 10.1023/a:1023246921127

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Stroke in estrogen receptor-alpha-deficient mice.

Authors:  K Sampei; S Goto; N J Alkayed; B J Crain; K S Korach; R J Traystman; G E Demas; R J Nelson; P D Hurn
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

2.  Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides.

Authors:  R C Dodel; Y Du; K R Bales; F Gao; S M Paul
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

3.  Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene.

Authors:  K M Robertson; L O'Donnell; M E Jones; S J Meachem; W C Boon; C R Fisher; K H Graves; R I McLachlan; E R Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

Authors:  C J Pike
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons.

Authors:  Y Goodman; A J Bruce; B Cheng; M P Mattson
Journal:  J Neurochem       Date:  1996-05       Impact factor: 5.372

6.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

Authors:  M X Tang; D Jacobs; Y Stern; K Marder; P Schofield; B Gurland; H Andrews; R Mayeux
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

7.  Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.

Authors:  L S Schneider; M R Farlow; V W Henderson; J M Pogoda
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene.

Authors:  C R Fisher; K H Graves; A F Parlow; E R Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.

Authors:  D B Dubal; H Zhu; J Yu; S W Rau; P J Shughrue; I Merchenthaler; M S Kindy; P M Wise
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  15 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.

Authors:  Fabio Di Domenico; Gabriella Casalena; Rukhsana Sultana; Jian Cai; William M Pierce; Marzia Perluigi; Chiara Cini; Alessandra Baracca; Giancarlo Solaini; Giorgio Lenaz; Jia Jia; Suzan Dziennis; Stephanie J Murphy; Nabil J Alkayed; D Allan Butterfield
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

Review 3.  Gender, sex steroid hormones, and Alzheimer's disease.

Authors:  Rebekah S Vest; Christian J Pike
Journal:  Horm Behav       Date:  2012-04-19       Impact factor: 3.587

4.  Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.

Authors:  Giovanni Savettieri; Demetrio Messina; Virginia Andreoli; Simona Bonavita; Carlo Caltagirone; Rita Cittadella; Deborah Farina; Maria Carolina Fazio; Paolo Girlanda; Francesco Le Pira; Maria Liguori; Alessandra Lugaresi; Ugo Nocentini; Arturo Reggio; Giuseppe Salemi; Gioacchino Tedeschi; Maria Trojano; Paola Valentino; Aldo Quattrone
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Ovariectomy enhances acetylcholinesterase activity but does not alter ganglioside content in cerebral cortex of female adult rats.

Authors:  Siomara C Monteiro; Francieli M Stefanello; Luciene P Vianna; Cristiane Matte; Jaqueline Barp; Adriane Belló-Klein; Vera M T Trindade; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

Review 6.  Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease.

Authors:  Ashley Adamson; Silas A Buck; Zachary Freyberg; Briana R De Miranda
Journal:  Curr Environ Health Rep       Date:  2022-10-06

7.  The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol.

Authors:  Candice M Brown; Emily Choi; Qing Xu; Michael P Vitek; Carol A Colton
Journal:  Neurobiol Aging       Date:  2007-06-05       Impact factor: 4.673

8.  The environmental estrogen bisphenol a inhibits estradiol-induced hippocampal synaptogenesis.

Authors:  Neil J MacLusky; Tibor Hajszan; Csaba Leranth
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

9.  Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans.

Authors:  Astrid Gutierrez-Zepeda; Ross Santell; Zhixin Wu; Marishka Brown; YanJue Wu; Ikhlas Khan; Christopher D Link; Baolu Zhao; Yuan Luo
Journal:  BMC Neurosci       Date:  2005-08-25       Impact factor: 3.288

10.  The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Authors:  Manuel Fernández Martínez; Xabier Elcoroaristizabal Martín; Luís Galdos Alcelay; Jessica Castro Flores; Juan María Uterga Valiente; Begoña Indakoetxea Juanbeltz; María Angeles Gómez Beldarraín; Josefa Moraza López; María Carmen Gonzalez-Fernández; Ana Molano Salazar; Rocio Bereincua Gandarias; Sandra Inglés Borda; Nuria Ortiz Marqués; Miryam Barandiarán Amillano; María Carrasco Zabaleta; Marian M de Pancorbo
Journal:  BMC Neurosci       Date:  2009-09-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.